-

ValGenesis to Host ValConnect Mumbai Focused on AI-Driven Validation

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in digital validation, will host ValConnect Innovation Day on Sept. 9 at the Hilton Mumbai International Airport, bringing together leaders from life sciences, technology, and manufacturing to examine the role of AI in validation, compliance, and quality across the GxP lifecycle.

ValConnect Mumbai will explore a central challenge facing life sciences organizations: how to scale AI while maintaining the governance, control, and regulatory compliance required in GxP environments.

Share

The one-day event, which concludes the 2026 ValConnect Innovation Day series, will focus on a central challenge facing life sciences organizations: how to scale AI while maintaining the governance, control, and regulatory compliance required in GxP environments.

Prem Iyangar, managing director and practice lead for Life Sciences Industry Technology at Accenture, will deliver the keynote on AI adoption trends in life sciences, including lessons learned, success stories, and what successful enterprise AI adoption looks like.

Leaders from Biocon, Alkem Laboratories, and Dr. Reddy's Laboratories will share their organizations’ experiences digitalizing validation and qualification with ValGenesis.

The event will also feature a panel discussion, "From Process Design to Continuous Verification: The Future of AI-Driven Validation," exploring how AI and digital technologies are transforming decision-making and product quality across the validation lifecycle. Moderated by ValGenesis Chief Marketing Officer David Medina, the panel will feature ValGenesis CEO and Chief Product Strategist Dr. Siva Samy; Sanjay R. Sharma, senior vice president at Zydus Group; and Iyangar.

ValGenesis experts will demonstrate AI-enabled capabilities within the ValGenesis Smart GxP™ platform, including the iClean™ application for digitalizing cleaning operations, and will discuss practical applications of AI in commissioning, qualification, and knowledge management.

“ValConnect Innovation Days are designed for life sciences leaders determined to lead the next era of AI-driven validation and compliance,” Medina said. “The discussions and real-world feedback we’ve gathered from attendees in Lisbon, North Carolina, and now Mumbai are directly informing our product roadmap as we build the next generation of AI-driven solutions to help organizations modernize their operations while maintaining compliance and confidence.”

To view the full agenda and register, visit the ValGenesis events page.

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. For nearly two decades, ValGenesis has helped life sciences companies digitize commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers accelerate delivery, strengthen compliance, and improve operational efficiency across the product lifecycle. For more information, visit valgenesis.com.

Contacts

Media Contact:
Althea D’Sylva, althea.dsylva@valgenesis.com

More News From ValGenesis, Inc.

ValGenesis Appoints David Horn as President 

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, the global leader in digital validation and lifecycle management solutions for the life sciences industry, today announced the appointment of David Horn as president, effective Oct. 5, 2026.Horn joins ValGenesis as the company expands its Smart GxP™ platform and VAL™ (ValGenesis AI) capabilities. As president, he will focus on strengthening the company’s financial and operating foundation, supporting global growth, and expanding relationships wit...

ValGenesis to Bring Real-World AI-Assisted Validation Insights to KENX Europe 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis will share real-world AI-assisted validation insights from customer pilots and production deployments at KENX Europe 2026....

Eugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSV

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in enterprise digital validation, announced that Eugia Pharmaceuticals, a global specialty pharmaceutical company, has gone live with ValGenesis to modernize computer system validation (CSV) processes across its sites in India. The deployment will help enhance compliance, improve operational efficiency, and support growth. Hyderabad-based Eugia Pharma, a subsidiary of Aurobindo Pharma, develops and markets complex generics. The...
Back to Newsroom